Welcome to Anagrammer Crossword Genius! Keep reading below to see if cefpodoxime is an answer to any crossword puzzle or word game (Scrabble, Words With Friends etc). Scroll down to see all the info we have compiled on cefpodoxime.
cefpodoxime
Searching in Crosswords ...
The answer CEFPODOXIME has 0 possible clue(s) in existing crosswords.
Searching in Word Games ...
The word CEFPODOXIME is NOT valid in any word game. (Sorry, you cannot play CEFPODOXIME in Scrabble, Words With Friends etc)
There are 11 letters in CEFPODOXIME ( C3D2E1F4I1M3O1P3X8 )
To search all scrabble anagrams of CEFPODOXIME, to go: CEFPODOXIME
Rearrange the letters in CEFPODOXIME and see some winning combinations
6 letters out of CEFPODOXIME
5 letters out of CEFPODOXIME
4 letters out of CEFPODOXIME
3 letters out of CEFPODOXIME
Searching in Dictionaries ...
Definitions of cefpodoxime in various dictionaries:
CEFPODOXIME - Cefpodoxime is an oral, third-generation cephalosporin antibiotic. It is active against most Gram-positive and Gram-negative organisms. Notable excep...
Word Research / Anagrams and more ...
Keep reading for additional results and analysis below.
| Cefpodoxime might refer to |
|---|
| Cefpodoxime is an oral, third-generation cephalosporin antibiotic. It is active against most Gram-positive and Gram-negative organisms. Notable exceptions include Pseudomonas aeruginosa, Enterococcus, and Bacteroides fragilis. Currently, it is only marketed as generic preparations in the USA, according to the FDA Orange Book. It is commonly used to treat acute otitis media, pharyngitis, sinusitis, and gonorrhea. It also finds use as oral continuation therapy when intravenous cephalosporins (such as ceftriaxone) are no longer necessary for continued treatment. * Cefpodoxime inhibits cell wall synthesis by inhibiting the final transpeptidation step of peptidoglycan synthesis in cell walls. It has well established pharmacokinetic profile with absorption of 50%. It is indicated in community acquired pneumonia, uncomplicated skin and skin structure infections, and uncomplicated urinary tract infections. * It was patented in 1980 and approved for medical use in 1989. |